Transcription factor NFE2L2 (nuclear factor, erythroid 2 like 2), also named NRF2, functions as an oncogene or tumor suppressor, it regulates the cellular antioxidant response and promotes cancer chemotherapy resistance, metastasis, and progression 26-28. Here, NFE2L2 is linked to cancer.